| P50 | author | Craig A. Elmets | Q110142695 |
| P2093 | author name string | Hui Li | |
| | Jun Li | |
| | Hui Xu | |
| | Donggou He | |
| | Nabiha Yusuf | |
| | John D Mountz | |
| P2860 | cites work | A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses | Q24630221 |
| | Myeloid-derived suppressor cells: linking inflammation and cancer | Q24641811 |
| | T helper 17 cells promote cytotoxic T cell activation in tumor immunity | Q24646584 |
| | Tumor-specific Th17-polarized cells eradicate large established melanoma | Q24648032 |
| | Structure and signalling in the IL-17 receptor family | Q24648045 |
| | Myeloid-derived suppressor cells as regulators of the immune system | Q28131637 |
| | Type, density, and location of immune cells within human colorectal tumors predict clinical outcome | Q28131662 |
| | IL-23 promotes tumour incidence and growth | Q28239522 |
| | Interferons, immunity and cancer immunoediting | Q28270336 |
| | Interleukin-17 family members and inflammation | Q28287876 |
| | Antagonistic roles of CD4+ and CD8+ T-cells in 7,12-dimethylbenz(a)anthracene cutaneous carcinogenesis | Q28681056 |
| | Microenvironmental regulation of metastasis | Q29547660 |
| | Regulation of immune responses by L-arginine metabolism | Q29614284 |
| | Subsets of myeloid-derived suppressor cells in tumor-bearing mice | Q29614297 |
| | Paradoxical roles of the immune system during cancer development | Q29614305 |
| | IL-17 enhances the susceptibility of U-2 OS osteosarcoma cells to NK cell lysis | Q57003139 |
| | Inflammation and necrosis promote tumour growth | Q80402773 |
| | Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells | Q82930126 |
| | Interleukin-12 and the regulation of innate resistance and adaptive immunity | Q29614602 |
| | Smoldering and polarized inflammation in the initiation and promotion of malignant disease | Q29618034 |
| | IL-17 family cytokines and the expanding diversity of effector T cell lineages | Q29619361 |
| | Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection | Q33556845 |
| | Myeloid-derived suppressor cells down-regulate L-selectin expression on CD4+ and CD8+ T cells | Q33567728 |
| | Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense | Q34087551 |
| | Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice | Q34729932 |
| | Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer | Q34843832 |
| | IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway | Q34989745 |
| | IL-17 and IFN-gamma mediate the elicitation of contact hypersensitivity responses by different mechanisms and both are required for optimal responses | Q35231916 |
| | CD8+ IL-17-producing T cells are important in effector functions for the elicitation of contact hypersensitivity responses | Q35231921 |
| | At the crossroads of inflammation and cancer | Q35888450 |
| | Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression | Q36259867 |
| | Effector-phase tolerance: another mechanism of how cancer escapes antitumor immune response | Q36369397 |
| | Regulatory T cells, tumour immunity and immunotherapy | Q36430144 |
| | S100A8 and S100A9 in inflammation and cancer | Q36538576 |
| | Immune resistance orchestrated by the tumor microenvironment | Q36593747 |
| | Regulatory T cells and cancer | Q36738385 |
| | T(H)-17 cells in the circle of immunity and autoimmunity | Q36765453 |
| | Interleukin-12: biological properties and clinical application | Q36910729 |
| | The tumor microenvironment and its role in promoting tumor growth | Q36946019 |
| | The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages | Q36959353 |
| | Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17 | Q36981811 |
| | Slit2 inhibits growth and metastasis of fibrosarcoma and squamous cell carcinoma | Q36982125 |
| | Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells. | Q37118160 |
| | Th17 cell differentiation: the long and winding road | Q37133442 |
| | Tumor escape mechanism governed by myeloid-derived suppressor cells | Q37138881 |
| | Type 17 CD8+ T cells display enhanced antitumor immunity. | Q37268980 |
| | Endogenous IL-17 contributes to reduced tumor growth and metastasis | Q37271039 |
| | The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans | Q37363065 |
| | Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity | Q40013431 |
| | Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment | Q40130406 |
| | TCR transgenic CD8+ T cells activated in the presence of TGFbeta express FoxP3 and mediate linked suppression of primary immune responses and cardiac allograft rejection | Q40233095 |
| | IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis | Q40360012 |
| | Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses | Q44158655 |
| | Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis. | Q54638927 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2281-2288 | |
| P577 | publication date | 2010-01-29 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | IL-17 promotes tumor development through the induction of tumor promoting microenvironments at tumor sites and myeloid-derived suppressor cells | |
| P478 | volume | 184 | |